Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Building a predictive model for warfarin dosing via machine learning

View through CrossRef
Abstract Background Warfarin titration via International Normalised Ratio (INR) monitoring can be a challenge for patients on long term anticoagulation due to its multiple drug interactions, long half life and patient's individual reponse, yet critically important due to its narrow therapeutic index. Machine learning may have a role in learning and replicating existing warfarin prescribing practices, to be potentially incorporated into an automated warfarin titration model. Purpose We aim to explore the feasibility of using machine learning to develop a model that can learn and predict actual warfarin titration practices. Methods A retrospective dataset of 4,247 patients with 48,895 data points of INR values were obtained from our institutional database. Patients who had less than 5 visits recorded, invalid or missing values were excluded. Variables studied included age, warfarin indication, warfarin dose, target INR range, actual INR values, time between titration and time in therapeutic range (TTR as defined by the Rosenthal formula). The machine learning model was developed on an unbiased training data set (1,805 patients), further refined on a handpicked balanced validation set (400 patients), before being evaluated on two balanced test sets of 100 patients each. The test sets were handpicked based on the criteria of TTR (“in vs out of range”) and stability of INR results (“low vs high fluctuation”) (Table 1). Given the time series nature of the data, a Recurrent Neural Network (RNN) was chosen to learn warfarin prescription practices. Long-short term memory (LSTM) cells were further employed to address the problem of time gaps between warfarin titration visits which could result in vanishing gradients. Results A total of 2,163 patients with 42,622 data points were studied (mean age 65±11.7 years, 54.7% male). The mean TTR was 65.4%. The total warfarin dose per week as predicted by the RNN was compared with actual total warfarin dose per week prescribed for each patient in the test sets. The coefficient of determination for the RNN in the “in vs out of range” and “low vs high fluctuation” test sets were 0.941 and 0.962 respectively (Figure 1). Conclusion This proof of concept study demonstrated that a RNN based machine learning model was able to learn and predict warfarin dosage changes with reasonable accuracy. The findings merit further evaluation of the potential use of machine learning in an automated warfarin titration model. Funding Acknowledgement Type of funding source: None
Title: Building a predictive model for warfarin dosing via machine learning
Description:
Abstract Background Warfarin titration via International Normalised Ratio (INR) monitoring can be a challenge for patients on long term anticoagulation due to its multiple drug interactions, long half life and patient's individual reponse, yet critically important due to its narrow therapeutic index.
Machine learning may have a role in learning and replicating existing warfarin prescribing practices, to be potentially incorporated into an automated warfarin titration model.
Purpose We aim to explore the feasibility of using machine learning to develop a model that can learn and predict actual warfarin titration practices.
Methods A retrospective dataset of 4,247 patients with 48,895 data points of INR values were obtained from our institutional database.
Patients who had less than 5 visits recorded, invalid or missing values were excluded.
Variables studied included age, warfarin indication, warfarin dose, target INR range, actual INR values, time between titration and time in therapeutic range (TTR as defined by the Rosenthal formula).
The machine learning model was developed on an unbiased training data set (1,805 patients), further refined on a handpicked balanced validation set (400 patients), before being evaluated on two balanced test sets of 100 patients each.
The test sets were handpicked based on the criteria of TTR (“in vs out of range”) and stability of INR results (“low vs high fluctuation”) (Table 1).
Given the time series nature of the data, a Recurrent Neural Network (RNN) was chosen to learn warfarin prescription practices.
Long-short term memory (LSTM) cells were further employed to address the problem of time gaps between warfarin titration visits which could result in vanishing gradients.
Results A total of 2,163 patients with 42,622 data points were studied (mean age 65±11.
7 years, 54.
7% male).
The mean TTR was 65.
4%.
The total warfarin dose per week as predicted by the RNN was compared with actual total warfarin dose per week prescribed for each patient in the test sets.
The coefficient of determination for the RNN in the “in vs out of range” and “low vs high fluctuation” test sets were 0.
941 and 0.
962 respectively (Figure 1).
Conclusion This proof of concept study demonstrated that a RNN based machine learning model was able to learn and predict warfarin dosage changes with reasonable accuracy.
The findings merit further evaluation of the potential use of machine learning in an automated warfarin titration model.
Funding Acknowledgement Type of funding source: None.

Related Results

Establishment of pharmacogenomic algorithm for predicting stable warfarin dose in Chinese patients
Establishment of pharmacogenomic algorithm for predicting stable warfarin dose in Chinese patients
Background Genetic variants of cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) are known to influence warfarin dose, but the effect of other...
untitled protocol v1
untitled protocol v1
Background: Warfarin is an oral anticoagulant associated with adverse reaction drugs due to wide inter- and intra-individual dosage variability. Warfarin dosage has been related to...
Group-Based Trajectory Analysis for Long-Term Use of Warfarin Therapy in Atrial Fibrillation Patients
Group-Based Trajectory Analysis for Long-Term Use of Warfarin Therapy in Atrial Fibrillation Patients
Atrial fibrillation (AF) patients suffer a high risk of ischemic stroke and other thromboembolism (TE). Warfarin is a long-term oral medication and is effective in reducing TE for ...
NOACs versus warfarin in people with atrial fibrillation and thyroid dysfunction
NOACs versus warfarin in people with atrial fibrillation and thyroid dysfunction
Anticoagulant therapy is an important measure to prevent stroke or other embolic events in patients with atrial fibrillation (AF). Warfarin, a classical anticoagulant, has a narrow...
Anticoagulant therapy for a patient with recurrent pulmonary embolism and warfarin resistance:a case report and literature review
Anticoagulant therapy for a patient with recurrent pulmonary embolism and warfarin resistance:a case report and literature review
Abstract Background Warfarin serves as a primary anticoagulant in the management of pulmonary embolism. This paper delves into the complexities of anticoagulant therapy in...
Establishing Warfarin Clinics for improved Anticoagulation Management in Ethiopia
Establishing Warfarin Clinics for improved Anticoagulation Management in Ethiopia
Warfarin is essential for preventing thromboembolic complications in patients with atrial fibrillation and prosthetic heart valves, who are at significant risk for stroke, systemic...

Back to Top